FI943315A0 - Farmaseuttinen valmiste pore- ja/tai hajoamistabletin tai pikarakeiden muodossa, samoin kuin menetelmä valmistaa niitä - Google Patents

Farmaseuttinen valmiste pore- ja/tai hajoamistabletin tai pikarakeiden muodossa, samoin kuin menetelmä valmistaa niitä

Info

Publication number
FI943315A0
FI943315A0 FI943315A FI943315A FI943315A0 FI 943315 A0 FI943315 A0 FI 943315A0 FI 943315 A FI943315 A FI 943315A FI 943315 A FI943315 A FI 943315A FI 943315 A0 FI943315 A0 FI 943315A0
Authority
FI
Finland
Prior art keywords
active ingredient
pct
matrix
amount
date jul
Prior art date
Application number
FI943315A
Other languages
English (en)
Swedish (sv)
Other versions
FI110353B (fi
FI943315A (fi
Inventor
Thomas Gergely
Irmgard Gergely
Original Assignee
Gergely Gerhard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gergely Gerhard filed Critical Gergely Gerhard
Publication of FI943315A0 publication Critical patent/FI943315A0/fi
Publication of FI943315A publication Critical patent/FI943315A/fi
Application granted granted Critical
Publication of FI110353B publication Critical patent/FI110353B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
FI943315A 1992-01-13 1994-07-12 Menetelmä farmaseuttisen valmisteen valmistamiseksi pore- ja/tai hajoamistabletin tai pikarakeiden muodossa FI110353B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92100441 1992-01-13
EP92100441 1992-01-13
EP9300055 1993-01-12
PCT/EP1993/000055 WO1993013760A1 (de) 1992-01-13 1993-01-12 Pharmazeutische zubereitung in form einer brause- und/oder zerfallstablette oder eines instantgranulats, sowie verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
FI943315A0 true FI943315A0 (fi) 1994-07-12
FI943315A FI943315A (fi) 1994-07-12
FI110353B FI110353B (fi) 2002-12-31

Family

ID=8209237

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943315A FI110353B (fi) 1992-01-13 1994-07-12 Menetelmä farmaseuttisen valmisteen valmistamiseksi pore- ja/tai hajoamistabletin tai pikarakeiden muodossa

Country Status (16)

Country Link
US (1) US5587179A (fi)
EP (1) EP0620731B1 (fi)
JP (1) JPH07506336A (fi)
AT (1) ATE128028T1 (fi)
AU (1) AU668375B2 (fi)
CA (1) CA2127352C (fi)
CZ (1) CZ283351B6 (fi)
DE (1) DE59300632D1 (fi)
DK (1) DK0620731T3 (fi)
ES (1) ES2068800T3 (fi)
FI (1) FI110353B (fi)
GR (2) GR950300005T1 (fi)
MX (1) MX9300110A (fi)
PL (1) PL173676B1 (fi)
WO (1) WO1993013760A1 (fi)
ZA (1) ZA93215B (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
TW466119B (en) * 1994-02-28 2001-12-01 Janssen Pharmaceutica Nv Film coated tablet of paracetamol and domperidone
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
US5837287A (en) * 1994-10-28 1998-11-17 R P Scherer Corporation Process for preparing solid pharmaceutical dosage forms
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6974595B1 (en) * 1996-05-17 2005-12-13 Proethic Pharmaceuticals, Inc. Pharmaceutical compositions based on Diclofenae
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
DE19822036A1 (de) * 1998-05-15 1999-11-18 Bayer Ag Brausezubereitungen
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
US7001612B2 (en) 1998-08-26 2006-02-21 All Sun Hsf Company Limited Composition for the relief of heat stress
US6235322B1 (en) * 1999-03-09 2001-05-22 Mintech, Inc. Highly soluble and stable mineral supplements containing calcium and magnesium
AP2002002410A0 (en) * 1999-08-04 2002-03-31 Ranbaxy Laboratories Ltd Hydrodynamically Balancing Oral Drug Delivery System
US6284270B1 (en) 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
DE60133723T2 (de) * 2000-02-28 2009-07-02 PharmaKodex Ltd., Chippenham Verabreichungssystemen für oral anzuwendende arzneimittel
AU2001275043A1 (en) 2000-05-31 2001-12-11 Drugtech Corporation Mineral supplement
GB0222612D0 (en) * 2002-09-30 2002-11-06 Univ Gent Controlled delivery system for bioactive substances
WO2004032906A1 (en) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Gastro-retentive levodopa delivery form
JP4601271B2 (ja) * 2003-08-01 2010-12-22 大洋薬品工業株式会社 圧縮成形製剤およびその製造方法
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP2009517346A (ja) 2005-11-28 2009-04-30 イメイジノット ピーティーワイ エルティーディー 治療用化合物の経口送達系
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
CN101084881B (zh) * 2007-06-23 2012-08-29 淮北辉克药业有限公司 靶向速释泡腾制剂及其制备方法
CA2704209C (en) 2007-10-31 2017-02-28 Mcneil-Ppc, Inc. Orally disintegrative dosage form
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US9610224B2 (en) 2009-09-24 2017-04-04 Johnson & Johnson Consumer Inc. Manufacture of tablet in a die utilizing powder blend containing water-containing material
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US20150366823A1 (en) 2013-02-06 2015-12-24 Hermes Arzneimittel Gmbh Pharmaceutical compositions incorporating low-dose drugs
KR20160107254A (ko) 2014-01-10 2016-09-13 존슨 앤드 존슨 컨수머 인코포레이티드 고주파 및 손실 코팅된 입자를 사용하여 정제를 제조하는 방법
WO2015193485A1 (en) 2014-06-20 2015-12-23 Hermes Arzneimittel Gmbh Taste-masked oral pharmaceutical composition
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289751A (en) * 1979-06-29 1981-09-15 Merck & Co., Inc. Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4539198A (en) * 1983-07-07 1985-09-03 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
US4832956A (en) * 1985-09-25 1989-05-23 Gerhard Gergely Disintegrating tablet and process for its preparation
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
NZ231281A (en) * 1988-11-08 1991-01-29 Takeda Chemical Industries Ltd Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition

Also Published As

Publication number Publication date
GR950300005T1 (en) 1995-02-28
US5587179A (en) 1996-12-24
WO1993013760A1 (de) 1993-07-22
AU3349293A (en) 1993-08-03
CZ283351B6 (cs) 1998-03-18
FI110353B (fi) 2002-12-31
ATE128028T1 (de) 1995-10-15
DE59300632D1 (de) 1995-10-26
EP0620731B1 (de) 1995-09-20
JPH07506336A (ja) 1995-07-13
ES2068800T1 (es) 1995-05-01
CA2127352A1 (en) 1993-07-22
DK0620731T3 (da) 1996-04-09
FI943315A (fi) 1994-07-12
GR3017806T3 (en) 1996-01-31
EP0620731A1 (de) 1994-10-26
ES2068800T3 (es) 1995-12-16
AU668375B2 (en) 1996-05-02
CZ160594A3 (en) 1994-12-15
MX9300110A (es) 1994-07-29
ZA93215B (en) 1993-08-19
PL173676B1 (pl) 1998-04-30
CA2127352C (en) 2005-05-31

Similar Documents

Publication Publication Date Title
FI943315A (fi) Farmaseuttinen valmiste pore- ja/tai hajoamistabletin tai pikarakeiden muodossa, samoin kuin menetelmä valmistaa niitä
IL111647A0 (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them
UA26455C2 (uk) Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта
CA2265766A1 (en) Rapidly disintegrating pellets
AP1526A (en) Sertraline salts and sustained-release dosage forms of sertraline.
GR3031135T3 (en) Compositions containing S(+)-Ibuprofen.
AU1537095A (en) Therapeutic agents containing thyroid hormones
FR2698788B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
YU76503A (sh) Farmaceutski aktivni estri uridina
HK1017615A1 (en) Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases.
JP2006273849A (ja) フェノフィブラート含有組成物
JPH03251526A (ja) 糖尿病依存型自己免疫疾患治療、予防用薬剤
AP2003002905A0 (en) Sertraline salts and sustained-release dosage forms of sertraline.
RU94044939A (ru) Терапевтическая композиция в форме таблеток содержащая парацетамол
YU20050413A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem